Coronavirus
Department

Viroscience

Our mission is to limit the clinical and public outcomes of high-impact virus infections through an integrated field-to-bench-to-bedside research program.

About our department

Our research

About the department of Viroscience

The Department of Viroscience of the Erasmus MC is an international centre of excellence for multidisciplinary, basic, translational and clinical research of viruses and virus infections at the molecular, patient and population level. The unique aspect of the Department of Viroscience is its translational approach, with expertise ranging from basic virology to clinical virology, connecting medical and veterinary health, public health and ecology. By combining these complementary areas of expertise The Department of Viroscience is able to meet today's and tomorrow's societal challenges in diseases caused by common and newly emerging viruses.

Global impact of the department of Viroscience

  • Discovery of the human metapneumovirus MERS CoV, and othersThe identification of camels as the reservoir for MERS CoV
  • Basic insights into how avian in uenza viruses and other zoonoses cause diseases in humans
  • Unravelling how avian influenza viruses can become transmissible for humans
  • Discovery of mechanism of norovirus evolution and its impact on population health
  • Support to WHO as collaborating centre for emerging viral infections
  • And many more

About new emerging viral infections

Viral infections like Ebola, MERS and SARS continue to be among the leading causes of illness and death across the world. They threaten the health of the global population if they are not rapidly detected and contained.They threaten the health of the global population if they are not rapidly detected and contained. Besides known viruses, new viruses continue to emerge due to rapid demographic changes over the past decades, as well as globalization of travel and trade? Zika virus is a recent example. Vaccines may have been developed for known viruses, however ageing of the population, and treatment strategies of persons with complex comorbidities, such as an impaired immune system, have also led to novel challenges in prevention and treatment. Common viral infections may have a severe impact on these patients in terms of morbidity, quality of life and on a community level in health care cost.

The Department of Viroscience is Reference Centre  for:

  1. WHO Collaborating Centre (WHO-CC) – Emerging Viral Infections
  2. WHO National Reference Laboratory Centre - Measles & Rubella
  3. National Reference Centre for Influenza and Emerging Infections in The Netherlands

Reference Centers

The Department of Virology of the Erasmus MC is:

  1. WHO Collaborating Centre (WHO-CC) – Emerging Viral Infections
  2. WHO National Reference Laboratory Centre - Measles & Rubella
  3. National Reference Centre for Influenza and Emerging Infections in The Netherlands 

1. WHO Collaborating Centre (WHO-CC)

Main activity of the Department of Virology (Viroscience) of the Erasmus MC as WHO Collaborating Centre is to support outbreak response operations during outbreaks of Emerging and Dangerous Pathogens coordinated by WHO. Examples of this are the contributions of the department in identifying the cause of SARS and MERS coronavirus, the studies unraveling the role of camels as sources MERS COV, support in investigations of Zika virus in Surinam and Brazil, and the operation of mobile laboratories during the Ebola outbreak in West Africa.

The Department of Virology (Viroscience) uses classical and newly developed state-of-the-art technology to identify known or new viral pathogens. This is possible because the Department of Virology has a wide-array of serological and molecular tests to identify known pathogens. Random priming sequencing technology is also available for unknown agents.

During response operations to outbreaks of Emerging and Dangerous Pathogens coordinated by WHO, the Department of Virology will be contacted by WHO to provide onsite laboratory diagnostic support with staff and equipment when possible. The field deployment of lab equipment or staff will be coordinated with WHO and partners involved in control operations. Depending on incriminated pathogen, the Department of Virology will provide lab diagnostic technology to rapidly, safely and accurately diagnose patient and support Surveillance, Case management and research projects.

The Department of Virology also provides technical support to National laboratories by providing (in limited quantities) reagents and diagnostic methods to national reference laboratories.
The Department of Virology (Viroscience) is WHO Collaborating Centre regarding Viral infections on the following terms of reference:

  • To cooperate with WHO in its function of alert and response to outbreaks of Emerging and Dangerous Pathogens of international importance, including outbreaks of Arboviruses, Viral Haemorrhagic Fevers and novel and emerging infectious diseases.
  • Support WHO in the early diagnosis, rapid identification and characterization of high-risk pathogens specimens submitted through WHO, keeping the results confidential, if so required.
  • During response operations to outbreaks of Emerging and Dangerous Pathogens coordinated by WHO, to assist with epidemiological surveys carried out under the responsibility of WHO by providing personnel and/or equipment when possible.
  • During response operations to outbreaks of Emerging and Dangerous Pathogens coordinated by WHO, to provide onsite laboratory diagnostic support with staff and equipment when possible.
  • Provide technical support to the national laboratories involved in epidemiological and laboratory investigations during Emerging Infectious Diseases outbreak responses.
  • To inform WHO of any epidemiological or laboratory finding that would be in conjunction with a risk of transmission of a severe disease of international concern: Arboviruses, Viral Haemorrhagic Fevers and novel and emerging infectious diseases.

2. WHO National Reference Laboratory Centre - Measles & Rubella

The Department of Virology (Viroscience) of the Erasmus MC is accredited as National Reference Laboratory for Measles and Rubella, as part of the WHO European Measles and Rubella Laboratory Network. This responsibility is shared with the National Institute of Public Health and the Environment, Center for Infectious Disease research, Diagnostics and Screening. The objective of the laboratory network is to document and verify elimination of measles and rubella from the WHO European Region, based on procedures developed for certification of the global eradication of smallpox and poliomyelitis.

Measles, rubella and congenital rubella syndrome are preventable through immunization. The diseases are important causes of global morbidity and mortality. All countries in the WHO European Region include highly effective and safe measles and rubella vaccines in their vaccination program. However, due to persistent gaps in immunization coverage outbreaks of measles and rubella continue to occur.

The WHO National Reference Laboratories have two main responsibilities:

  • Case-based laboratory diagnosis of suspected measles and rubella cases, and reporting of confirmed cases to the surveillance system;
  • Genotyping of measles and rubella viruses, and reporting viral sequences to the surveillance systems MeaNS and RubeNS.

All WHO regions have elimination goals for measles and rubella. The criteria for the verification of measles elimination are documentation of the interruption of endemic measles and rubella for a period of more than 36 months in the presence of an adequate surveillance system that can detect import-related cases. This must be supplemented with genotyping data that support the interruption of endemic transmission.

These efforts should eventually lead to the ultimate goal of global eradication of measles and rubella.

3. National Reference Centre for Influenza and Emerging Infections in The Netherlands

The Department of Virology (Viroscience) is National Reference Centre for Influenza and Emerging Infections in the Netherlands.

Influenza surveillance Newsletters

You can find the Influenza Newsletters (in DUTCH): here

Want to sign up for the Infuenza surveillance nieuwsbrieven? Please, send an e-mail to: nic@erasmusmc.nl ( in DUTCH)

 

 

 

Research Lines

Research organization

Our research program has two main pillars:

  1. One health (research lines 1, 2, 3)

    As a result of world-wide changes in climate, land use, and animal management, there is an increased risk of zoonotic viruses crossing the species barrier, adapting to the human host, and gaining human-to-human transmissibility, resulting in novel epidemics or pandemics. The main goal of this research pillar is to provide the basic, translational and clinical research needed to develop evidence-based detection, prevention, treatment and intervention strategies against zoonotic viruses with potential to cause epidemics and pandemics.
  2. Personalised health (research lines 4, 5, 6, 7)

    Due to major demographic changes in our population, the group of high-risk patients (elderly, immuno-compromised, patients with complex co-morbidities, prematurely born children) is increasing, resulting in an increased burden of disease due to acute and chronic infections with a range of viruses. The main goal of this pillar is to improve detection, prevention and intervention strategies against such virus infections at the patient level.

Research line 1

Emerging Infectious disease research preparedness and response in a One Health context.

Research line 2:

Emerging disease (immune)pathogenesis, and medical countermeasures.

Research line 3:

Influenza virus ecology, evolution, pathogenesis, and public health impact

Research line 4:

Immunopathogenesis of paramyxoviruses and pneumoviruses

Research line 5:

NeuroImmune Biology of Virus Infections (NIMBUS)

Research line 6:

HIV and HCV

Research line 7: 

Clinical Virology

Laboratory for Calcium and Bone Metabolism

The overall aim of the research group is to understand the mechanisms behind skeletal disorders and discover novel therapeutic targets for the treatment of disturbances in bone and mineral homeostasis.

Viroscience: Clinical Virology

The overall aim of this research line is to improve diagnosis, triaging, monitoring and treatment for an increasing patient population at risk of complications due to a range of co-morbidities

Viroscience: Emerging disease (immune)pathogenesis, and medical countermeasures

The overall objective of this research line is to unravel key pathogenic pathways for selected EID as a basis for future interventions and medical countermeasures.

Viroscience: Emerging Infectious disease research preparedness and response in a One Health context

Overall objective is to reduce impact of emerging infectious diseases through development of risk based-prediction and early warning tools, state-of-the-art reference diagnostics, and rapid research response during outbreaks.

Viroscience: HIV and HCV

The pathogenesis, prevention and treatment of chronic viral infections.

Viroscience: Immunopathogenesis of paramyxoviruses and pneumoviruses

The overall aim of this research line is to understand the interaction of paramyxo- and pneumoviruses and the host in order to identify correlates of disease or protection, understand viral mechanisms of immune evasion, and use these insights to develop intervention strategies.

Viroscience: Influenza virus ecology, evolution, pathogenesis and public health impact

The overall objective of this research line is to reduce the impact of epidemic and pandemic influenza through research on viruses in reservoir hosts, transient hosts, and humans, and to develop mitigation strategies based on surveillance, vaccines and antivirals..

Viroscience: NeuroImmune Biology of Virus Infections (NIMBUS)

The overall aim of this research line is to decrease the impact of virus-induced neurological diseases through detailed knowledge of the complex tripartite interaction between viruses, the human nervous system and the immune system.

Principal Investigators

Projects

  • BARDA 
  • Brains4Viruses
  • CEPI
  • COMPARE
  • CORSURV
  • CRIP
  • DELTA-FLU
  • DUCAMID (NWO Caribbean)
  • ECRAID-plan
  • EFSA NGS Noro
  • EFSA Wild
  • EHVA
  • Epitope Mapping
  • EVAg
  • EVDLabNet
  • FLUCOP
  • INITIATE ETN Marie Curie
  • METASTAVA
  • Mrace, Innovative HIV prevention strategies based on transmission networks in Rotterdam
  • Mrace, Treatment for chronic norovirus infections
  • Nophame, Marie Curie IF
  • NWA-ORC Preparing for vector-borne virus outbreaks in a changing world: a One Health Approach
  • PREPARE
  • RECODID
  • RIVM - ECDC Surveillance
  • RIVM emerging infections
  • RIVM Flu Research
  • SHARP 
  • Simon Stevin
  • Single cell T-cell
  • STW Environmental safety
  • Support Casper
  • VetBioNet
  • Vidi Respiratory Viruses
  • Vidi, Identifying determinants of respiratory virus transmission between mammals
  • ZAPI (IMI )
  • ZIKAlliance
  • ZikaRisk
  • Zoonoses in the night

Notable results

Societal relevance results

  • Discovery of the human metapneumovirus, MERS CoV, and others.
  • The identification of camels as the reservoir for MERS CoV.
  • Basic insights into how avian influenza viruses and other zoonoses cause diseases in humans.
  • Unravelling how avian influenza viruses can become transmissible for humans.
  • Discovery of mechanism of norovirus evolution and its impact on population health.
  • Support to WHO as collaborating centre for emerging viral infections.

Collaboration

ECO Health Alliance - The Department of Virology is closely involved in the Eco Health Alliance. 

NCOH - The Department of Viroscience is one of the founding partners of NCOH, in addition to Utrecht University, Wageningen University & Research Centre, University Medical Center Utrecht and Academic Medical Centre Amsterdam.

NORONET - The Department of Virology of the Erasmus MC is partner of NoroNet., an informal network of scientists working in public health institutes or universities sharing virological, epidemiological and molecular data on the norovirus. 

OVIT Consortium - De OVIT consortium is a Dutch consortium focused on delivering effective solutions in pancreatic cancer; a multidisciplinary team that includes virologists, paediatric oncologists and neurosurgeons from Erasmus MC, LUMC and UMC Utrecht.

RODIN - Regional Rotterdam Infectious Diseases Network

News, events and awards

Our news

 
surveillance and prediction of EIDs.
News | January 17, 2020

15 million for development early detection system for infectious diseases outbreaks

“Our ambition is to revolutionize our ability to detect and analyze outbreaks of emerging disease at a much earlier stage than currently is possible, thus allowing time to respond rapidly to seriously curtail their impact,” says prof Marion Koopmans, head of department of Viroscience at Erasmus MC Rotterdam, and coordinator of the VEO project. The project started January 1st 2020, and will receive funding for 5 years.

tien vragen marion youtube
News | April 2, 2020

About Marion Koopmans and her answers to nine coronaquestions

Learn more from world's top doctors

diagram a new twenty-first century science
News | November 8, 2019

A new twenty-first century science for effective epidemic response

With rapidly changing ecology, urbanization, climate change, increased travel and fragile public health systems, epidemics will become more frequent, more complex and harder to prevent and contain.

Annemiek spotify fb
News | March 21, 2020

Annemiek van der Eijk: How do we deal with coronavirus

The coronavirus has gripped us all. Social distancing is the new reality. What else can we do to prevent spreading? Can we still go outside? Does it help to wear mouth masks? What about our immunity and can our pets be infected? Listen to this podcast from March 20 on Spotify (In Dutch)

Annemiek spotify fb
News | March 21, 2020

Annemiek van der Eijk: How do we deal with coronavirus

The coronavirus has gripped us all. Social distancing is the new reality. What else can we do to prevent spreading? Can we still go outside? Does it help to wear mouth masks? What about our immunity and can our pets be infected? Listen to this podcast from March 20 on Spotify (In Dutch)

Annemiek bij NOS
News | March 17, 2020

Annemiek van der Eijk over thuisblijvende schoolkinderen

NOS journaal van 16 maart 2020

Bart Haagmans aan lafkast
News | March 10, 2020

Bart Haagmans: coronavirus may also be transferable with mild symptoms

The coronavirus may not only cause clear flu-like symptoms, but also very mild symptoms. There is a chance that carriers with mild symptoms will also spread the virus. That says virologist Bart Haagmans, who is researching the virus at Erasmus MC in Rotterdam.

bloedafname bij can you become immune to the coronavirus
News | April 3, 2020

Can you become immune to the coroanvirus?

It’s likely you can, at least for some period of time. That is opening new opportunities for testing and treatment.

ruigdwerrgvleermuis 400 x 300
News | February 6, 2020

Dutch bats infected with 2019-nCoV?

Are bats in the Netherlands also infected with 2019-nCoV? Based on genetic research, the # 2019-nCoV is most similar to #coronaviruses found in specimens of a type of horseshoe nose (Rhinolophus affinis) sampled in Yunnan province, #China. This bat species is widely distributed in South and Southeast Asia, but not in Europe.

Coronavirus
News | January 30, 2020

Erasmus MC conducts research on Coronavirus

Virologists from the Virology Department work closely with the WHO. Prof. Marion Koopmans and Dr. Bart Haagmans participate in the WHO virologists group – in which virologists from all over the world are affiliated. The virology department has – if necessary – tests available to determine whether someone has the coronavirus.

philogenetische boom 640 x 384
News | March 16, 2020

Family tree shows path of the virus

Where exactly do new infections with the coronavirus come from? To answer that question, geneticists look at the pedigree of the virus. Marion Koopmans explains. (in Dutch)

introplaatje 400 x 387
News | February 28, 2020

How Disease X, the-epidemic-in-waiting, erupted in China

Marion Koopmans, Erasmus University Medical Centre: This is a new disease, it’s threatening to the world, it’s socially disrupting, and we need to come up with ways of detecting it, controlling it, treating it, preventing it on the fly – to me, that is a Disease X

Marion 1 vandaag
News | March 17, 2020

Marion Koopmans bij Een Vandaag

Uitzending van 16 maart 2020

fotovideo rijnmond Marion
News | February 28, 2020

Marion Koopmans: coronavirus is not so contagious at all

Outside on the street, mouth caps do not appear to have any effect, even though the virus is not so contagious at all", says Koopmans. "But what we do see is that a whole group of people get sick if you don't pay attention properly."

europ science-media hub
News | April 3, 2020

Marion Koopmans: "We will see more of this if we topple natural balances"

Interview on the COVID-19 pandemic with WHO expert Prof. Marion Koopmans, Virologist and Veterinary, Director of Virosciences, Erasmus MC, Rotterdam. She was appointed, together with six other leading European experts, as a member of the advisory panel on COVID-19 of the European Commission.

camel nieuws marion
News | October 17, 2019

Mini symposium “Zoonotic disease emergence: lessons learned and future directions

Tuesday November 26, 2019 Time: 09:00 - 12.00 Mini symposium "Zoonotic disease emergence: lessons learned and future directions"

marion podcastbericht agora
News | March 5, 2020

Podcast Marion Koopmans, Can we stop the coronavirus

And what's the best approach? Marion Koopmans talks about it in this podcast. As a virologist at Erasmus MC and advisor to international bodies such as the WHO, she is engaged in the fight against infectious diseases. She sees that solving and preventing global outbreaks is becoming increasingly complex, partly because the worlds of humans and animals are increasingly merging. The Virology department, which Koopmans leads, is involved in solving the secrets behind the coronavrirus (SARS-CoV-2) but also behind all kinds of other viruses, from herpes to Ebola. In this broadcast you also hear who man is behind this inspired virologist. "She can teach you how to do 1,000 things at once."

EM foto Coronavirus
News | February 27, 2020

Preparing for the Next Pandemic: The Emerging Infectious Disease Threat

Emerging infectious diseases are relatively little understood. Their periodic, unpredictable outbreaks can quickly transform into global pandemics, as was the case with SARS and avian influenza. They tend to be zoonotic (deriving from an animal source), infect thousands of people at a time, engender significant fear and panic, and have high mortality rates, which is frequently because the public infrastructure to diagnose, prevent and treat them is lacking. Newer examples of these diseases include MERS and Ebola, both of which are RNA viruses with the ability to mutate from one outbreak to the next, making them that much deadlier.

videofoto Q&A corona Marion Koopmans
News | February 28, 2020

Q & A about coronavirus with Marion Koopmans

Virologist Marion Koopmans of Erasmus MC was a guest with us. Viewers could ask her questions about the new coronavirus (COVID-19). You can look back at the question session here. (in Dutch)

Rik new yorker
News | April 3, 2020

Rik de Swart in the New Yorker; How does the coronavirus behave insie a patient?

“I want to emphasize that measles and COVID-19 are different diseases caused by very different viruses with different behaviors,” Rik de Swart, a virologist at Erasmus University, in Rotterdam, cautioned when we spoke, “but in measles there are several clear indications that the severity of illness relates to the dose of exposure.

youtubescherm can corona be stopped
News | March 13, 2020

Studio Erasmus: Can the coronavirus be stopped?

A new virus broke out in the Wuhan region of China at the end of last year: the coronavirus, or SARS severe acute respiratory syndrome -CoV coronavirus -2. Measures are being taken worldwide to prevent further spread of the virus. But is that still possible? On the eve of the virus outbreak of the Netherlands, Marion Koopmans was interviewed by Geert Maarse from studio Erasmus. Short video Marion Koopmans – Studio Erasmus – Erasmus University Rotterdam (in Dutch)

vimeo knaw
News | February 27, 2020

Video-registration-about-the-new-coronavirus

Coronaviruses generally cause mild respiratory infections in humans. However, we also know the SARS and MERS variants, which cause serious diseases. On Friday 21 February 2020, the Academy organised a meeting on the new coronavirus.

Marion uitkijk over rotterdam
News | March 21, 2020

Virologist Marion Koopmans: "The hectic pace does not make it easy to get people along"

There is so much attention for the coronavirus that the media cycle has gone through, says virology professor Marion Koopmans. That limits her and her colleagues in their work to fight this new virus. Read the article by Raymond Krul, 13 March 2020. Photography by Duco de Vries.

In the media

Corona in the media

A collection of Corona news can also be found here

Reggeborgh schenkt 50.000 euro voor corona-onderzoek
destentor.nl, 31 March 2020, Bart Haagmans

Een vaccin tegen coronavirus niet binnen een jaar verwacht
ad.nl, 31 March 2020, Bart Haagmans

Wanneer ben je beschermd tegen het coronavirus?
kijknieuws.nl, 27 March 2020, Marion Koopmans

Spliterwten en Slaolie
nrc.nl, Martijn Katan, 27 March 2020, Ron Fouchier

Immuniteit tegen virus vervaagt al na een paar jaar
Trouw, 27 March 2020, Marion Koopmans

COVID-19 webinar krijgt vervolg
vphuisartsen.nl, 25 March 2020, Eric van Gorp

Langzaam richting smoren
de Groene Amsterdammer, 25 March 2020, Marion Koopmans

Wel of niet doen? Buiten spelen in de tijd van coronacrisis.
indebuurt.nl, 23 March 2020, Bart Haagmans

Carolien krijgt reacties uit de hele wereld op corona-onderzoek
De Twensche Courant Tubantia ed. Reggestreek, 23 March 2020, Carolien van der Sandt

Virus van morgen
NPO 2, VPRO Tegenlicht, 22 March 2020, Ron Fouchier

Leerlingen Walburg College krijgen les in virology
hendrik-ido-ambacht.dekombinatie.nl, 21 March 2020, viruskenner

Het is officieel lente, maar de winter heeft een verlaat staartje
rtlnieuws.nl, 20 March 2020, Bart Haagmans

Interview Nieuws en Co
NPO Radio 1, 19 March 2020, Marion Koopmans

Een vaccine voor het coronavirus laat nog zeker een jaar op zich wachten
drimble.nl, 19 March 2020, Bart Haagmans

Landelijke bloedtest om te zien of in Nederland immuniteit tegen corona ontstaat?
parool.nl, 19 March 2020, Marion Koopmans

Mag een kankerpatiënt bezocht worden en kan een 80-jarige nog de deur uit?
NOS.nl, 18 March 2020, Annemiek van der Eijk

Mexicaanse of Spaanse griepvirus: welk scenario volgt het coronavirus?
geotrendlines.nl, 18 March 2020, Marion Koopmans

Interview Nieuwsuur
NPO 2, Nieuwsuur, 18 March 2020, Marion Koopmans

Wat moet een virus doen om een pandemie te veroorzaken?
Quest, 17 March 2020, Marion Koopmans, Ron Fouchier

Hoe gevaarlijk kan een pandemie worden?
Newsmonkey.be, 17 March 2020, Ron Fouchier

Luchtruim en scholen sluiten weinig zin als horeca openblijft
Caribischnetwerk.ntr.nl, 16 March 2020, Byron Martina

Interview Eén Vandaag
NPO 1,  16 March 2020, Marion Koopmans 

Misverstand over coronavirus: "Niet alleen ouderen worden ziek, ook jongeren"
RTLNieuws, 16 March 2020

Omgaan met de corona-lockdown
BNR-Ask Me Anything, podcast, 16 March 2020, Eric van Gorp

Extra lange uitzending over coronacrisis
hartvannederland.nl, 15 March 2020, Marion Koopmans

Nederland steunt rigoureuze maatregelen kabinet in strijd tegen coronavirus
hartvannederland.nl, 15 March 2020, Marion Koopmans

Annemiek van der Eijk geeft antwoord op de vragen van kinderen
NPO 3, Jeugdjournaal, 15 March 2020, Annemiek van der Eijk

Stamboom toont pad van het virus
NRC Handelsblad, 14 March 2020

Zijn we af van corona als het straks zomer wordt?
de Volkskrant, 13 March 2020, Ron Fouchier
 
Verspreiding en aanpak van het coronavirus
WNL, Goedemorgen Nederland, 13 March 2020, Marion Koopmans

Marathon Rotterdam, Gold Race en GP Zandvoort ook in het gedrang?
Algemeen Dagblad, 10 March 2020, Marion Koopmans

Jounaal 07.00 uur
NPO 1 Radio journaal. 10 March 2020, Eric van Gorp

Kan uw huisdier ook besmet raken met coronavirus?
www.maxvandaag.nl, 10 March 2020, Thijs Kuiken

Vijf minuten met Marion Koopmans
NPO radio 1, 9 March 2020, Marion Koopmans

60 nieuwe coronabesmettingen, de meeste in Brabant. Wat is er aan de hand?
Trouw, 7 March 2020, Marion Koopmans

Belangrijkste verschil met griep is dat er voor coronavirus geen vaccin is.
NOS.nl, 2 March 2020, Eric van Gorp

Updates, nieuwe besmettingen in Nederland
BNR.nl, 2 March 2020, Eriv van Gorp

Wat gebeurt er als het coronavirus het lichaam binnendringt?
de Volkskrant, 3 March 2020, Bart Haagmans

Chloroquine is nog 'geen' wondermiddel
de Stentor, 29 Februari 2020, Bart Haagmans

A completely new culture of doing research. Coronavirus outbreak changes how scientists communicate
Science Magazine, 26 Februari 2020, Marion Koopmans

Q and A with Marion
NOS, 26 Februari 2020, Marion Koopmans

Pandemic prep: What you should know to protect against coronavirus
New York Post, 25 Februari 2020, Marion Koopmans

'Ik zou zó het vliegtuig naar China pakken'
NPO radio 1, 1 op 1, 31 Januari 2020, Marion Koopmans

Reageert Nederland té ontspannen?
NPO radio 1, Spraakmakers, 28 Januari 2020

De wereld houdt de adem in
Mens & Molecule, 26 Februari 2020, Marion Koopmans

Draaiboeken liggen klaar mocht coronavirus in Nederland opduiken
WNL op zaterdag, 25 Januari 2020, Marion Koopmamns

 

 

Overige berichten:

Nationale Griepprikdag
MaxVandaag, 11 November 2019

Duizenden wetenschappers roepen 'klimaatnoodtoestand' uit
MSN, 7 November 2019

Mazelen nóg schadelijker dan gedacht
BNR, 3 November 2019

Na mazelen is afweersysteem landurig afgezwakt
NPO Radio 1, 1 November 2019

Mazelen wissen geheugencellen afweersysteem
Vakblad Vroeg, 1 November 2019

Hoe de zorg zich schrap zet voor de horrorgriep
de Volkskrant, 1 November 2019

Griepprikken door vertraging met vaccins later gezet
de Gelderlander, 24 October 2019

Vrij onderzoek is cruciaal. Investeer er dan ook in
NRC, 11 October 2019

Straatvraag: Haal jij de griepprik
Rijnmond Nieuws, 8 October 2019

10 million for One Health research in the Netherlands
Erasmus MC, 12 juni 2019

Measles erases the immune system’s memory
ScienceNews, 21 May 2019

Kunnen mensen dieren ziek maken?
NRC, 17 May 2019

Disease X is not science fiction
NCOH, 17 May 2019

Marion Koopmans lunched with Royal couple
NOS, 9 May 2019

Marion Koopmans elected as KNAW member
KNAW, 24 April 2019

Measles Cases Continue to Soar, Stirring Concern Over Long-Term Effects 
The Wall Street Journal, 15 April 2019

Taking Emerging Infections to Task
Elsevier, 12 April 2019

 

Awards and grants

Recent awards and grants within our department:

  • Prof. Marion Koopmans: NWA-ORC Preparing for vector-borne virus outbreaks in a changing world: a One Health Approach. June 2019. Read all about it.
  • Prof. Marion Koopmans: Marion Koopmans elected as KNAW member. April 2019. Read all about it.
  • Dr. Rory de Vries: Beijerink Virology Prize awarded by the Royal Netherlands Academy of Arts and Sciences. January 2019. Read all about it.
  • Dr. Sander Herfst: The Heine-Medin Award 2018 granted by the European Society of Clinical Virology. October 2018. Read all about it.
  • Prof. Marion Koopmans: NWO Stevin Prize, the highest distinction in Dutch science. September 2018. Read all about it.
  • Prof. Marion Koopmans: honorary doctorate from the Technical University of Denmark (DTU). September 2018. Read all about it.
  • Debby van Riel: Vidi-grant by the Netherlands Organisation for Scientific Research (NWO). Awarded June 2018. Read the NWO press release.
  • Debby van Riel named member of the Young Erasmus Academy by the Erasmus Universiteit Rotterdam. March 2018. Read all about it. (Dutch)
  • My Phan: Marie Curie Individual Fellowship. March 2018. Read all about it.
  • Prof. Guus Rimmelzwaan: Alexander von Humboldt Professorship, the most extensive German grant awarded to scientific research. May 2017. Read our press release. (Dutch)
  • Prof. Ron Fouchier: Huibregtsen Prize for top innovative science with societal impact. October 2013. Read all about it.
  • Prof. Ron Fouchier: named one of the world's 100 Most Influential People by Time Magazine. 2012. Read all about it.

Career opportunities

Vacancies

Any questions?

Please contact our office if you have any questions or comments.

Contact